Evan Kidder (@EvanJKidder) profile picture

LSUHS 2029 MD/PhD Student. Translational Pathology Researcher in the Dhanesha Lab studying Monocytes in CKD

Shreveport, LA
Joined January 2015
Evan Kidder retweeted
We’re hiring! Tenure-track faculty position in cancer research at LSU Health Shreveport (Pathology & Translational Pathobiology). Looking for investigators building programs at the interface of cancer, metabolism, inflammation, and vascular biology. lsuhsc.edu/shv/CareerOpportu…
15
3
33
4,550
CAP President-elect Qihui "Jim" Zhai, MD, FCAP, is set to become the CAP's 39th President in just a few days. In this video, Dr. Zhai reflects on his journey from China to the United States and shares his hopes and goals for his presidency brnw.ch/21wVG0l
2
11
1,274
Evan Kidder retweeted
New #AHAJournals #Review summarizes the current state of knowledge of molecular mechanisms of interleukin-1 release from cells in atherosclerotic plaques. #Atherosclerosis #Inflammation #AlfaidiLab @EvanJKidder @Siddhartha55801 @LSUHS @ShefUni_ClinMed ahajrnls.org/3x5N6de
2
5
1,248
Evan Kidder retweeted
“How to Release or Not Release, That Is the Question.” A Review of Interleukin‐1 Cellular Release Mechanisms in #Vascular#Inflammation A complex regulatory map of IL-1α/β Synthesis, Secretion & Signaling NLRP3 Inflammasome "Therapeutic Options Modulating IL‐1β Before or After the Release?" Great point! Does the cellular sources of IL-1β matter, as it can be secreted by both immune cells & vascular wall-resident cells? How does the current IL-1β-targeting strategy impact the bioavailability of circulating vs vascular wall ligands? Does intracellular IL-1β have a signaling role before its secretion? Very thoughtful/insightful review👍 Highly recommended for #Atherosclerosis researchers! @EvanJKidder @Siddhartha55801 @MaAlfaidi @JAHA_AHA 2024 ahajournals.org/doi/full/10.…
1
14
64
5,579
This was very exciting to work on! If you are looking for a review of IL-1 in vascular biology and/or recent developments in #IL-1 therapeutics, give it a read!
Our review article on #IL-1 in #VascularInflammation. In this article we summarized the recent therapeutics, and identified the gaps in targeting IL-1 pathway! ahajournals.org/doi/full/10.… @JAHA_AHA @EvanJKidder @Siddhartha55801 @ShefUni_ClinMed
5
14
1,756
Excited to end the week on a great note! Coming out soon: our review article on my passion #IL-1 in #atherosclerosis. A 15 years of observation, and two years of writing, two cycles of revisions!! Thank you to @JAHA_AHA for accepting our work! Very-well done @EvanJKidder!!!
6
2
1
32
2,016
The Woolard Lab is Hiring: There is an open Post-Doc position to work on an NIH-Funded project investigating Lipin-1, macrophage Function, and atherosclerosis. #PostDocOpportunity #ScienceJobs #ResearchOpportunity. Please Apply: lsuhsc.edu/shv/CareerOpportu…
13
2
18
6,883
The Last Symposium of the YEAR 2023 @vascularbiology 🤩👇👇. We will learn about the "Other" Vascular System in Health and Disease!! #Lipidemia, #Immunity, #Development!
Our next #NAVBO Symposium is Tuesday, December 19th 2023 at 1 pm EST "All About the Lymphatics" with... Prof. Mark Nicolls @StanfordMed Dr. Vincenza Cifarelli @cifarelli_v @slusom Dr. Xiaolei Liu @xiaolei38006391 Organized by @MaAlfaidi Register at bit.ly/3Rzhvbp
7
25
3,756
Dr Peter Libby is loved by many people. In this lecture, he reviews the interplay between atherosclerosis, metabolic syndrome, and inflammation. It's open to all! Just sit back, relax, and watch it: eas.to/OpenDec23 @ProfKausikRay
39
3
94
10,607
Check out the latest #atvbnet post by @RachelCahalane ATVB_net: Article Commentary: The effects of aging, diet, medication and exercise on the imaging features of arterial calcium deposits ahajrnls.org/3Ri9c2C
11
1
39
2,948
Pro-IL-1β cleavage by chymase represents a previously unappreciated mechanism to generate active IL-1β in the vessel wall, independent of inflammasomes or caspases @MurrayClarkeLab @society_eas 🔗atherosclerosis-journal.com/…
3
11
1,168
Genetic & molecular mechanisms driving sex differences in CAD remain understudied. (Epi)genetic studies suggests sex differences in vascular remodeling, lipid metabolism and endothelial function 🔗atherosclerosis-journal.com/… @mete_civelek @JeanetteErdmann @gpasterkamp @DiezBenavente
14
1
42
4,465
👇very much needed🔦 Confirms the need for sex-specific discovery research but also need to question & call out clinical RCTs which continue to have <40% women enrolled😞
Women are characterized by a more atherogenic lipid profile from infancy to early adulthood and from middle age to old age 🔗atherosclerosis-journal.com/… @HolvenKirsten @j_rvl @society_eas
3
16
2,825
2023 PRACTICE-CHANGING CLINICAL TRIALS #recap ~~ a thread 🧵 ~~ 👇
7
170
7
525
118,193
#Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in patients undergoing #PCI: the TAPER-S randomised trial bit.ly/47VjbkP @AgewallStefan @FeliceGragnano @DDamario @ItaloPorto2 #EHJPharmacotherapy #ESCYoung
1
67
4
149
19,396
Evan Kidder retweeted
#ResearchLetter: Epitranscriptomic Modification of MicroRNA Increases Atherosclerosis Susceptibility ahajournals.org/doi/10.1161/…
6
1
16
4,043
Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction, by Moroni et al internationaljournalofcardio… @AbbateAntonio
1
7
786